{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T08:15:06Z","timestamp":1697271306184},"reference-count":30,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2007,1,15]],"date-time":"2007-01-15T00:00:00Z","timestamp":1168819200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell Proliferation"],"published-print":{"date-parts":[[2007,2]]},"abstract":"<jats:p><jats:bold>Abstract.\u2002<\/jats:bold>  <jats:italic>Objectives\/Background<\/jats:italic>: In biological terms, progression means that malignancy increases as genetic mutations accumulate leading to increased proliferation and invasion capacity. By verifying the proliferation capacity, human telomerase reverse transcriptase (hTERT) expression and <jats:italic>in vitro<\/jats:italic> invasion, in a group of highly malignant glioblastomas, benign meningiomas and astrocytomas, at the initial stage of progression, we have analysed putative progression <jats:italic>in vitro<\/jats:italic> for proliferation and telomerase expression. <jats:italic>Materials and Methods<\/jats:italic>: The relative proliferation status (visualized with Ki\u201067 antibodies) and presence of hTERT protein was analysed in 27 intracranial tumours (6 astrocytomas, 8 glioblastomas and 13 meningiomas) by immunohistochemistry on paraffin\u2010embedded biopsy tissue, as well as on primary tumour\u2010derived cell cultures. A confrontation model was used to analyse invasiveness <jats:italic>in vitro<\/jats:italic>. <jats:italic>Results<\/jats:italic>: The mean proliferation indices were 22.3 (SD\u00a0=\u00a018.1) for glioblastomas and 2.1 (SD\u00a0=\u00a01.9) for low\u2010grade (LG) astrocytomas. The group of benign meningiomas had a labelling index of 2.2 (SD\u00a0=\u00a02.7). Mean percentages of staining for hTERT varied between 36.5 (SD\u00a0=\u00a028.4) for glioblastomas and 10.2 (SD\u00a0=\u00a08.6) for LG astrocytomas. The group of benign meningiomas had a labelling index of 12.4 (SD\u00a0=\u00a019.2) for hTERT. A significant difference was seen for Ki\u201067 (<jats:italic>P\u00a0&lt;<\/jats:italic>\u00a00.05) and hTERT (<jats:italic>P\u00a0&lt;<\/jats:italic>\u00a00.001) <jats:italic>in vivo<\/jats:italic> versus <jats:italic>in vitro<\/jats:italic>. No difference was seen between the group of invasive and non\u2010invasive tumour\u2010derived cell cultures for the histopathological markers Ki\u201067 and hTERT (<jats:italic>P<\/jats:italic>\u00a0&gt;\u00a00.05) <jats:italic>in vitro<\/jats:italic>. <jats:italic>Conclusions<\/jats:italic>: The elevated expression of hTERT and Ki\u201067 <jats:italic>in vitro<\/jats:italic> provides a potential prognostic tool for early detection of the progression of brain tumours. As tumour cells require telomerase for continued proliferation, the expression of hTERT may mark immortality, leading to indefinite life span. On the other hand, hTERT expression and cell proliferation are not linked directly to invasion <jats:italic>in vitro<\/jats:italic>.<\/jats:p>","DOI":"10.1111\/j.1365-2184.2007.00415.x","type":"journal-article","created":{"date-parts":[[2007,1,15]],"date-time":"2007-01-15T09:40:19Z","timestamp":1168854019000},"page":"14-23","source":"Crossref","is-referenced-by-count":9,"title":["Progression of astrocytomas and meningiomas: an evaluation <i>in vitro<\/i>"],"prefix":"10.1111","volume":"40","author":[{"given":"L.","family":"Maes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. P. O.","family":"Kalala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Cornelissen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"De Ridder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,1,15]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-437X(01)00268-4"},{"key":"e_1_2_6_3_1","first-page":"11","article-title":"Analysis of telomerase activity levels in breast cancer: positive detection at the in situ breast carcinoma stage","volume":"3","author":"Bednarek AK","year":"1997","journal-title":"Clin. Cancer Res."},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s004280100466"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199908)188:4<395::AID-PATH376>3.0.CO;2-E"},{"key":"e_1_2_6_6_1","first-page":"4135","article-title":"Cell cycle and proliferation markers in neuroepithelial tumors","volume":"17","author":"Cavalla P","year":"1997","journal-title":"Anticancer Res."},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00701-003-0096-0"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1992.tb05245.x"},{"key":"e_1_2_6_9_1","first-page":"4301","article-title":"High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favourable histology Wilms\u2019 tumor","volume":"59","author":"Dome JS","year":"1999","journal-title":"Cancer Res."},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00381-002-0562-7"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2000.93.4.0618"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4652(199907)180:1<10::AID-JCP2>3.0.CO;2-D"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0090-3019(86)90233-8"},{"key":"e_1_2_6_14_1","first-page":"2319","article-title":"Can recurrence of meningiomas be predicted?","volume":"24","author":"Kalala JP","year":"2004","journal-title":"Anticancer Res."},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.7605428"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0047-6374(01)00223-8"},{"key":"e_1_2_6_17_1","unstructured":"KleihuesP CaveneeWK(2000).Pathology and genetics of tumours of the nervour system.World Health Organisation Classification of Tumours pp.176\u2013184. Lyon:IARC Press."},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63446-3"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.7.3339"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2004.01892.x"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2184.2005.00325.x"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1208232"},{"key":"e_1_2_6_23_1","first-page":"95","volume-title":"Culture de Cellules Animales: M\u00e9thodologies\u2010Applications","author":"De Ridder L","year":"2003"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006123-199212000-00009"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4652(199711)173:2<266::AID-JCP33>3.0.CO;2-B"},{"key":"e_1_2_6_26_1","first-page":"1","article-title":"Telomere shortening may contribute to aging and cancer: a perspective","volume":"2","author":"Shay JW","year":"1994","journal-title":"Mol. Cell. Differ."},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/0168-9525(93)90209-Z"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng1297-498"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00418-004-0645-5"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1006\/excr.2002.5541"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1997.4757"}],"container-title":["Cell Proliferation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2184.2007.00415.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2184.2007.00415.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T23:20:03Z","timestamp":1697239203000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2184.2007.00415.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,15]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["10.1111\/j.1365-2184.2007.00415.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2184.2007.00415.x","archive":["Portico"],"relation":{},"ISSN":["0960-7722","1365-2184"],"issn-type":[{"value":"0960-7722","type":"print"},{"value":"1365-2184","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,15]]}}}